apolipoprotein A-I Paris

variant of Apo A-I characterized for a Cys for Arg substitution at position 173 and 151 leading to the formation of homodimers and heterodimers with apo A-II; has been sequenced

Also Known As:

apoAI Paris; apolipoprotein AI Paris

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Lipids: 114793
- Lipoproteins: 18361
  - Apolipoproteins: 14925
    - Apolipoproteins A: 1020
      - Apolipoprotein A-I: 3926
        apolipoprotein A-I Paris: 1
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Lipoproteins: 18361
    - Apolipoproteins: 14925
      - Apolipoproteins A: 1020
        Apolipoprotein A-I: 3926
        apolipoprotein A-I Paris: 1
  - Apoproteins: 638
    - Apolipoproteins: 14925
      - Apolipoproteins A: 1020
        Apolipoprotein A-I: 3926
        apolipoprotein A-I Paris: 1

Experts

1.	Dickson, George: 1 article (09/2003)
2.	Graham, Ian: 1 article (09/2003)
3.	Manzano, Anna: 1 article (09/2003)
4.	Mohri, Zahra: 1 article (09/2003)
5.	Ogris, Manfred: 1 article (09/2003)
6.	Owen, James S: 1 article (09/2003)
7.	Sperber, Galia: 1 article (09/2003)

Related Diseases

1.	Heart Diseases (Heart Disease) 09/01/2003 - "Paradoxically, two natural variants of apoAI, termed apoAI(Milano) and apoAI(Paris), are associated with low HDL, but nevertheless provide remarkable protection against heart disease for heterozygous carriers and may even lead to longevity. "